Cytokinetics (NASDAQ:CYTK) Director L Patrick Gage acquired 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were bought at an average price of $6.55 per share, for a total transaction of $65,500.00. Following the completion of the purchase, the director now owns 30,000 shares in the company, […]
